TSE:HBP Helix BioPharma (HBP) Stock Price, News & Analysis C$1.17 +0.10 (+9.35%) (As of 10/22/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarnings About Helix BioPharma Stock (TSE:HBP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Helix BioPharma alerts:Sign Up Key Stats Today's RangeC$1.17▼C$1.3350-Day RangeC$0.22▼C$1.3452-Week RangeC$0.80▼C$1.35Volume4,263 shsAverage Volume3,179 shsMarket CapitalizationC$57.35 millionP/E RatioN/ADividend Yield1.50%Price TargetN/AConsensus RatingN/A Company OverviewHelix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.Read More… Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Receive HBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address HBP Stock News HeadlinesHBP:CA Helix BioPharma Corp.August 3, 2024 | seekingalpha.comHelix Biopharma: Fiscal Q2 Earnings SnapshotMay 13, 2024 | washingtonpost.comWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonOctober 22, 2024 | Porter & Company (Ad)Canadian Investment Regulatory Organization Trading Halt - HBPMarch 28, 2024 | ca.finance.yahoo.comHelix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsOctober 10, 2023 | finance.yahoo.comHelix BioPharma Corp. Announces Closing of Private Placement of CAD $3 Million and Board ChangesAugust 22, 2023 | stockhouse.comHelix Biopharma GAAP EPS of -C$0.01June 14, 2023 | msn.comHelix BioPharma Corp. Announces Fiscal 2023 Third Quarter ResultsJune 14, 2023 | finance.yahoo.comSee More Headlines HBP Stock Analysis - Frequently Asked Questions How have HBP shares performed this year? Helix BioPharma's stock was trading at C$0.21 on January 1st, 2024. Since then, HBP stock has increased by 457.1% and is now trading at C$1.17. View the best growth stocks for 2024 here. How do I buy shares of Helix BioPharma? Shares of HBP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Helix BioPharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Helix BioPharma investors own include Enterprise Products Partners (EPD), GrowGeneration (GRWG), Green Thumb Industries (GTBIF), Amplify Seymour Cannabis ETF (CNBS), Cenovus Energy (CVE), Enbridge (ENB) and Micron Technology (MU). Company Calendar Today10/22/2024Next Earnings (Estimated)10/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:HBP CUSIPN/A CIKN/A Webwww.helixbiopharma.com Phone+1-416-9253232FaxN/AEmployees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-6,140,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-2,220.62% Return on Assets-279.98% Debt Debt-to-Equity Ratio773.67 Current Ratio0.74 Quick Ratio1.04 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.10 per share Price / Cash Flow11.32 Book ValueC($0.01) per share Price / Book-117.00Miscellaneous Outstanding Shares49,020,000Free FloatN/AMarket CapC$57.35 million OptionableNot Optionable Beta-0.84 10 Best Stocks to Own in 2025Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio. Get This Free Report This page (TSE:HBP) was last updated on 10/22/2024 by MarketBeat.com Staff From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredElection rigged? We caught them red-handed…What happens if NOBODY will be elected the next President of the United States on Nov. 5? Not Donald Trump...Banyan Hill Publishing | SponsoredIt’s delivered 859% in 2.5 months…We’ve gotten a lot of messages asking… what should we buy if Trump wins? What should we buy if Kamala wins?...The Oxford Club | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredAfter calling a 2,269% gain, here’s his NEXT tradeReady for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredNext opportunity for crypto millionsAs we enter crypto's golden quarter (October-December), this coin is primed for takeoff. The best part? Mos...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.